1. Home
  2. TLS vs XOMA Comparison

TLS vs XOMA Comparison

Compare TLS & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telos Corporation

TLS

Telos Corporation

HOLD

Current Price

$5.76

Market Cap

463.8M

Sector

Technology

ML Signal

HOLD

Logo XOMA Corporation

XOMA

XOMA Corporation

HOLD

Current Price

$32.23

Market Cap

457.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLS
XOMA
Founded
1969
1981
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
463.8M
457.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
TLS
XOMA
Price
$5.76
$32.23
Analyst Decision
Buy
Strong Buy
Analyst Count
5
2
Target Price
$7.75
$69.50
AVG Volume (30 Days)
1.1M
53.6K
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.82
Revenue
$144,400,000.00
$47,106,000.00
Revenue This Year
$47.80
$88.91
Revenue Next Year
$26.19
$13.80
P/E Ratio
N/A
$39.11
Revenue Growth
17.44
118.02
52 Week Low
$1.83
$18.35
52 Week High
$8.36
$39.92

Technical Indicators

Market Signals
Indicator
TLS
XOMA
Relative Strength Index (RSI) 41.42 42.97
Support Level $5.68 $31.18
Resistance Level $5.99 $32.78
Average True Range (ATR) 0.55 1.53
MACD -0.04 0.00
Stochastic Oscillator 13.26 24.73

Price Performance

Historical Comparison
TLS
XOMA

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: